Lexicon Pharmaceuticals
LXRX
94 hedge funds and large institutions have $802M invested in Lexicon Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 40 closing their positions.
38% more call options, than puts
Call options by funds: $22K | Put options by funds: $16K
32% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 28
23% more capital invested
Capital invested by funds: $654M → $802M (+$148M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less funds holding
Funds holding: 119 → 94 (-25)
60% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 40
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
126
Profund Advisors
Bethesda,
Maryland
| – | -$12K | -1,812 | Closed |
|
|
BDF
127
Balasa Dinverno & Foltz
| – | -$11K | -1,714 | Closed |
|
128
D.E. Shaw & Co
New York
| – | -$11K | -1,685 | Closed |
|
129
Ameriprise
Minneapolis,
Minnesota
| – | -$11K | -1,611 | Closed |
|
130
BNP Paribas Financial Markets
Paris,
France
| – | -$5.42K | -824 | Closed |
|
|
HI
131
Hudock Inc
Williamsport,
Pennsylvania
| – | -$3K | -429 | Closed |
|
|
LTFS
132
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$1K | -143 | Closed |
|
|
HCM
133
Highlander Capital Management
Short Hills,
New Jersey
| – | +$308 | +42 | New |
|
LXRX Hedge Fund Activity: Q2 2015 in Review
94 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q2 2015, worth a combined $802M — up 23% from $654M a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of LXRX and 16 opened new positions — a net loss of 24 holders — while 28 trimmed existing stakes and 37 added.
The largest buyer was UBS AM, adding an estimated $7.36M. The largest seller was Sabby Management, cutting an estimated $3.29M.
- 94 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q2 2015, down from 119 in Q1 2015.
- Funds reported $802M of Lexicon Pharmaceuticals stock for Q2 2015, up 23% quarter-over-quarter.
- 16 funds opened new Lexicon Pharmaceuticals positions in Q2 2015 and 40 closed out, a net change of -24 holders.
- The largest Lexicon Pharmaceuticals buyer in Q2 2015 was UBS AM, an estimated $7.36M added.
- The largest Lexicon Pharmaceuticals seller in Q2 2015 was Sabby Management, an estimated $3.29M sold.
Based on aggregated 13F filings for Q2 2015.